We are live on
!
Find out more
MIM
MetLife Investment Management Portfolio holdings
AUM
$22.1B
1-Year Est. Return
45.54%
This Fund
S&P 500
This Quarter
Est. Return
-3.28%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
–
AUM
$15.4B
AUM Growth
+$3.25B
(+27%)
Cap. Flow
+$3.84B
Cap. Flow
% of AUM
24.9%
Top 10 Holdings %
Top 10 Hldgs %
24.83%
Holding
2,819
New
321
Increased
2,347
Reduced
46
Closed
92
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$246M |
| 2 |
Microsoft
MSFT
|
+$216M |
| 3 |
Amazon
AMZN
|
+$130M |
| 4 |
Tesla
TSLA
|
+$79.6M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$73.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$49.3M |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$11.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$11.6M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$5.56M |
| 5 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$5.52M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.05% |
| 2 | Healthcare | 12.29% |
| 3 | Financials | 12.2% |
| 4 | Consumer Discretionary | 11.42% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
Teva Pharmaceuticals
TEVA
$42.6B
| $711K | ﹤0.01% |
75,753
| – | – |
|
|
CNR
1552
Core Natural Resources Inc
CNR
$4.71B
| $710K | ﹤0.01% |
18,860
+6,113
| +48% | +$177K |
|
1553
Opko Health
OPK
$1.04B
| $710K | ﹤0.01% |
206,296
+85,349
| +71% | +$301K |
|
1554
Marcus & Millichap
MMI
$1.18B
| $710K | ﹤0.01% |
13,471
+4,743
| +54% | +$227K |
|
|
SVC
1555
Service Properties Trust
SVC
$1.06B
| $708K | ﹤0.01% |
16,044
+5,327
| +50% | +$232K |
|
|
PRO
1556
DELISTED
PROS Holdings
PRO
| $708K | ﹤0.01% |
21,261
+6,014
| +39% | +$185K |
|
1557
Krispy Kreme
DNUT
$569M
| $708K | ﹤0.01% |
47,655
+38,533
| +422% | +$578K |
|
|
CSR
1558
Centerspace
CSR
$925M
| $707K | ﹤0.01% |
7,203
+1,887
| +35% | +$183K |
|
1559
Comstock Resources
CRK
$4.09B
| $707K | ﹤0.01% |
54,147
+19,984
| +58% | +$178K |
|
1560
Editas Medicine
EDIT
$432M
| $707K | ﹤0.01% |
37,148
+13,546
| +57% | +$252K |
|
1561
US Physical Therapy
USPH
$1.22B
| $706K | ﹤0.01% |
7,102
+2,693
| +61% | +$257K |
|
|
APTS
1562
DELISTED
Preferred Apartment Communities, Inc.
APTS
| $705K | ﹤0.01% |
28,268
+10,020
| +55% | +$217K |
|
1563
Phreesia
PHR
$780M
| $704K | ﹤0.01% |
26,712
+9,698
| +57% | +$297K |
|
1564
BGC Group
BGC
$5.12B
| $701K | ﹤0.01% |
159,292
+61,209
| +62% | +$271K |
|
1565
First Busey Corp
BUSE
$2.58B
| $701K | ﹤0.01% |
27,656
+9,178
| +50% | +$253K |
|
|
SHYF
1566
DELISTED
The Shyft Group
SHYF
| $701K | ﹤0.01% |
19,406
+6,878
| +55% | +$292K |
|
|
ARGO
1567
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $700K | ﹤0.01% |
16,963
+6,293
| +59% | +$302K |
|
1568
Archrock
AROC
$5.84B
| $700K | ﹤0.01% |
75,819
+26,498
| +54% | +$227K |
|
|
ANAT
1569
DELISTED
American National Group, Inc. Common Stock
ANAT
| $699K | ﹤0.01% |
3,695
+970
| +36% | +$183K |
|
|
ADAM
1570
Adamas Trust
ADAM
$913M
| $698K | ﹤0.01% |
47,794
+19,887
| +71% | +$291K |
|
1571
Stem
STEM
$55.9M
| $697K | ﹤0.01% |
3,165
+1,128
| +55% | +$263K |
|
1572
M/I Homes
MHO
$3.82B
| $691K | ﹤0.01% |
15,591
+5,684
| +57% | +$290K |
|
1573
Ingles Markets
IMKTA
$1.66B
| $691K | ﹤0.01% |
7,760
+2,849
| +58% | +$242K |
|
1574
Deluxe
DLX
$1.09B
| $688K | ﹤0.01% |
22,763
+8,367
| +58% | +$263K |
|
|
TPTX
1575
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $686K | ﹤0.01% |
25,538
+9,050
| +55% | +$304K |
|
Similar funds
BA
FAM
CAM
VARA
CHP
MIC
OAG
MetLife Investment Management's Q1 2022 Portfolio in Review
As of Q1 2022, MetLife Investment Management held 2,819 positions worth $15.4B, up 27% from $12.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
MetLife Investment Management deployed $3.84B of net new capital in Q1 2022, opening 321 new positions and adding to 2,347 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $49.3M trimmed.
- MetLife Investment Management's largest Q1 2022 buy was iShares Russell 1000 Growth ETF: 519,200 shares worth $36M.
- MetLife Investment Management added most to Apple in Q1 2022, an estimated $246M increase.
- MetLife Investment Management's biggest Q1 2022 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $49.3M.
- MetLife Investment Management fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $11.7M.
- MetLife Investment Management's ten largest holdings make up 25% of its $15.4B portfolio in Q1 2022.
- MetLife Investment Management opened 321 new positions and closed 92 in Q1 2022.
- MetLife Investment Management's portfolio value rose 27% quarter-over-quarter to $15.4B.
Based on MetLife Investment Management's 13F filing for Q1 2022, filed 12 May 2022.